News

Cathie Wood, CEO of ARK Invest, remains bullish on Tesla, despite the stock's decline, citing its strong position in the autonomous vehicle race and potential for robotaxis to transform the company into a software powerhouse. However, her flagship ARK Innovation ETF (ARKK) has underperformed the market, raising questions about her investment strategy.

Berkshire Hathaway has paused its share buyback program as its stock nears an all-time high, despite outperforming the S&P 500 this year. The company's strong performance and high stock price may lead to continued buyback abstinence throughout the year, potentially impacting future financial strategies and investor sentiment.

U.S. forces, in collaboration with Iraqi intelligence and security services, killed a high-profile ISIS leader, Abdallah Makki Muslih al-Rifai, in a precision airstrike in western Iraq. The operation marks a significant victory in the fight against terrorism, as al-Rifai was a key figure in the organization, overseeing global operations, logistics, and financial matters.

Employees of JPMorgan Chase are suing the company, alleging that its prescription drug plan, overseen by CVS Health, has been paying exorbitant prices for medications. This lawsuit is part of a growing trend of similar cases against major employers, raising questions about the role of employers and pharmacy benefit managers in the rising costs of healthcare in the US.

Elon Musk is facing criticism from investors for his divided attention between Tesla and his role in the Trump administration, which has coincided with protests, vandalism, and declining sales in Europe. Despite support from some conservatives, investor confidence remains low due to Musk's absence from Tesla and the lack of clarity on his plans for the company.